Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-13 DUGAN RICHARD W Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2018-06-13 MILANO VINCENT Director Grant or award +5,000 10,000
2018-06-13 MILANO VINCENT Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2018-06-13 Watkins Thomas Director Grant or award +5,000 25,000
2018-06-13 Watkins Thomas Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2018-05-03 Watkins Thomas Director Option exercise +15,000 $4.98 $75K 20,000
2018-05-03 Watkins Thomas Director Option exercise · Stock Option (Right to Buy) +15,000 0
2018-03-19 DUGAN RICHARD W Director Option exercise +15,000 $4.98 $75K 25,770
2018-03-19 DUGAN RICHARD W Director Option exercise · Employee Stock Option (Right to Buy) +15,000 0
2018-03-01 Polymeropoulos Mihael Hristos President and CEO Sale −60,966 $18.72 $1.1M 1,182,872
2018-03-01 Kelly James Patrick EVP & Chief Financial Officer Sale −8,532 $18.72 $160K 199,534
2018-03-01 Gulino Richard L. SVP, General Counsel & Sec. Sale −3,660 $18.71 $68K 115,073
2018-03-01 Birznieks Gunther SVP, Business Development Sale −8,525 $18.72 $160K 139,841
2018-02-28 Reverberi Gian Piero SVP & Chief Commercial Officer Grant or award +30,000 140,000
2018-02-28 Reverberi Gian Piero SVP & Chief Commercial Officer Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2018-02-28 Polymeropoulos Mihael Hristos President and CEO Grant or award +60,000 1,243,838
2018-02-28 Polymeropoulos Mihael Hristos President and CEO Grant or award · Employee Stock Option (Right to Buy) +140,000 140,000
2018-02-28 Kelly James Patrick EVP & Chief Financial Officer Grant or award +40,000 208,066
2018-02-28 Kelly James Patrick EVP & Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +80,000 80,000
2018-02-28 Gulino Richard L. SVP, General Counsel & Sec. Grant or award +30,000 118,733

Page 19 of 20 · 387 trades